Last reviewed · How we verify

NCT04268914

Virtual Reality to Reduce Pre-Operative Anxiety

Suspended NA Last updated 27 October 2023
What this trial tests

NA trial testing Oculus Go VR in Virtual Reality in 450 participants. Suspended.

Timeline
4 December 2015
Primary endpoint
6 December 2026
6 December 2026

Quick facts

Lead sponsorChildren's Hospital Los Angeles
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment450
Start date4 December 2015
Primary completion6 December 2026
Estimated completion6 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital Los Angeles

Who can join

Adults 10 to 21, any sex, with Virtual Reality or Augmented Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test the effectiveness of virtual reality (VR) as a non-pharmaceutical intervention to reduce pain and anxiety in children undergoing various procedures in the Ambulatory Surgery Center (ASC) at CHLA, as measured by self- and proxy-report.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oculus Go VR

Trials testing the same drug.

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Other Children's Hospital Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04268914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing